---
title: "Doxorubicin Hydrochloride Injectable, Liposomal (Zydus) Updated"
id: "dailymed-updates-8-doxorubicin-hydrochloride-injectable-liposomal-zydus-pharmaceuticals-usa-inc-"
canonical_url: "https://medichelpline.com/clinical-feed/dailymed-updates-8-doxorubicin-hydrochloride-injectable-liposomal-zydus-pharmaceuticals-usa-inc-"
content_type: "clinical_feed_article"
specialty: "Pharmacology"
source_name: "DailyMed Drug Label Updates"
source_url: "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=15a84bd6-b565-4722-bb92-e4c919620a90&version=5"
published_at: "2026-03-27T04:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Doxorubicin Hydrochloride Injectable, Liposomal (Zydus) Updated
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/dailymed-updates-8-doxorubicin-hydrochloride-injectable-liposomal-zydus-pharmaceuticals-usa-inc-
- **Specialty:** [Pharmacology](https://medichelpline.com/clinical-feed/pharmacology.md)
- **Primary Source:** DailyMed Drug Label Updates
- **Source URL:** [Original Journal Publication](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=15a84bd6-b565-4722-bb92-e4c919620a90&version=5)
- **Published At:** 2026-03-27T04:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
DailyMed Drug Label Updates published a clinical update in Pharmacology on 27 Mar 2026. The item focuses on DOXORUBICIN HYDROCHLORIDE injectable, liposomal [Zydus Pharmaceuticals USA Inc.]. Review the original article for the full source wording and details.
## Clinical Analysis & Structured Key Points
DailyMed Drug Label Updates published a clinical update in Pharmacology on 27 Mar 2026. The item focuses on DOXORUBICIN HYDROCHLORIDE injectable, liposomal [Zydus Pharmaceuticals USA Inc.]. Review the original article for the full source wording and details.
## Related Clinical Research

- [Organelle‑Resolved Tetrazine–trans‑Cyclooctene Click Chemistry for Targeted Cargo Delivery and Rel](https://medichelpline.com/clinical-feed/pubmed-42225547.md) (DOI: 10.1002/chem.71198)
- [Zwitterionic PEGylation (EK) for Liposomes to Reduce Immunogenicity and Improve Delivery](https://medichelpline.com/clinical-feed/pubmed-42680140.md) (DOI: 10.1021/acsami.6c12129)
- [Surface Chemistry and pH Control Structural Dynamics and Drug Binding in PETIM and PAMAM Dendrimers](https://medichelpline.com/clinical-feed/biorxiv-18-surface-functionality-and-ph-govern-structural-dynamics-and-drug-binding-in.md)
- [Cu(II) Coordination Enhances Doxorubicin DNA Binding: Integrated Computational and Spectroscopic S](https://medichelpline.com/clinical-feed/biorxiv-7-integrated-computational-and-spectroscopic-analyses-to-unravel-the-role-of-cu.md)
- [Response-Adapted Bladder Preservation in MIBC: RETAIN-2 Phase II Results and ctDNA Dynamics](https://medichelpline.com/clinical-feed/medrxiv-2-response-adapted-bladder-preservation-in-muscle-invasive-bladder-cancer-results.md)

## Navigation
- [← Back to Pharmacology Feed](https://medichelpline.com/clinical-feed/pharmacology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.